Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal

Author: Sugarbaker, Paul

Source: Annals of Surgical Oncology, Volume 17, Number 6, June 2010 , pp. 1710-1712(3)

Publisher: Springer

Document Type: Research article

DOI: http://dx.doi.org/10.1245/s10434-010-1042-z

Affiliations: 1: Program in Peritoneal Surface Malignancy, Washington Hospital Center, Washington, DC, USA, Email: paul.sugarbaker@medstar.net

Publication date: 2010-06-01

• In this: publication
• By this: publisher
• In this Subject: Oncology
• By this author: Sugarbaker, Paul

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers